196-210 of 2681
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
On the Frontlines of Prostate CancerActive Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
On the Frontlines of Prostate CancerPersonalizing Prostate Cancer Surveillance: Insights from Canary PASS
Advancing COPD Care: AI-Driven Tools for Enhanced Imaging
On the Frontlines of COPDAdvancing COPD Care: AI-Driven Tools for Enhanced Imaging
A New Era in COPD Care: Exploring Breakthrough Bronchoscopic Treatments
On the Frontlines of COPDA New Era in COPD Care: Exploring Breakthrough Bronchoscopic Treatments
Understanding the Complex Link Between PIF, Inhaler Choice, and COPD Outcomes
On the Frontlines of COPDUnderstanding the Complex Link Between PIF, Inhaler Choice, and COPD Outcomes
Examining Psoriasis Prevalence: Diagnostic Differences Across Demographics
On the Frontlines of PsoriasisExamining Psoriasis Prevalence: Diagnostic Differences Across Demographics
- advertisement
Recognizing Asthma-COPD Overlap: Clinical Clues and Diagnostic Strategies
On the Frontlines of COPDRecognizing Asthma-COPD Overlap: Clinical Clues and Diagnostic Strategies
Assessing Competitive Bidding’s Effect on COPD Oxygen Utilization
On the Frontlines of COPDAssessing Competitive Bidding’s Effect on COPD Oxygen Utilization
Asthma-COPD Overlap Management: Integrating Dual Treatment Pathways
On the Frontlines of COPDAsthma-COPD Overlap Management: Integrating Dual Treatment Pathways
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
On the Frontlines of Prostate CancerEvolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
ADT Monotherapy for mHSPC: How to Identify the Right Patients
On the Frontlines of Prostate CancerADT Monotherapy for mHSPC: How to Identify the Right Patients
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
On the Frontlines of Prostate CancerRedefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
- advertisement
Pediatric Responses to SARS-CoV-2: What We’ve Learned So Far
Clinician's RoundtablePediatric Responses to SARS-CoV-2: What We’ve Learned So Far
COPD in Japan vs. the US: Comparing Prevalence and Mortality Rates
On the Frontlines of COPDCOPD in Japan vs. the US: Comparing Prevalence and Mortality Rates
Moderna’s 2024–2025 COVID-19 Vaccine: Composition Updates and Interim Effectiveness Data
Clinician's RoundtableModerna’s 2024–2025 COVID-19 Vaccine: Composition Updates and Interim Effectiveness Data
